Company attributes
Venture Capital Firm attributes
Other attributes
Deutsche Effecten -und Wechsel Beteiligungsgesellschaft is a private equity firm based in Germany that invests in early and later stage ventures. Founded 1997 in Jena, Thuringen, Germany, this private equity firm invests in early and late stage ventures. Its portfolio companies include Nanda Technologies, Sloning BioTechnology, Nanotron Technologies, SensorDynamics, Sloning BioTechnology, and Noxxon Pharma. As of February 2020, Deutsche Effecten -und Wechsel Beteiligungsgesellschaft has made seven investments. Their most recent investment was on Apr 8, 2010, when Nanda Technologies raised $4M. Deutsche Effecten -und Wechsel Beteiligungsgesellschaft has had four exits, the most notable of which include Noxxon Pharma, Nanda Technologies, and Sloning BioTechnology. The company focuses on companies in German-speaking countries within the areas of photonics and sensor systems .